NPT
JNJ icon

Nixon Peabody Trust’s Johnson & Johnson JNJ Stock Holding History

Nixon Peabody Trust’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Buy
22,335
+517
+2% +$120K 0.4% 58
2026
Q1 		$5.33M Sell
21,818
-4,704
-18% -$1.1M 0.42% 58
2025
Q4 		$5.49M Sell
26,522
-2,086
-7% -$413K 0.42% 62
2025
Q3 		$5.3M Sell
28,608
-1,379
-5% -$236K 0.39% 65
2025
Q2 		$4.58M Sell
29,987
-10,168
-25% -$1.56M 0.35% 65
2025
Q1 		$6.66M Sell
40,155
-54,336
-58% -$8.5M 0.57% 50
2024
Q4 		$13.7M Sell
94,491
-12,696
-12% -$1.97M 1.13% 32
2024
Q3 		$17.4M Sell
107,187
-1,315
-1% -$210K 1.45% 22
2024
Q2 		$15.9M Sell
108,502
-3,134
-3% -$466K 1.41% 23
2024
Q1 		$17.7M Buy
111,636
+4,942
+5% +$787K 1.62% 18
2023
Q4 		$16.7M Buy
106,694
+92,406
+647% +$14.2M 1.88% 13
2023
Q3 		$2.23M Buy
14,288
+8,935
+167% +$1.47M 1.86% 16
2023
Q2 		$886K Buy
5,353
+3,982
+290% +$643K 0.72% 49
2023
Q1 		$213K Sell
1,371
-268
-16% -$43.3K 0.15% 62
2022
Q4 		$290K Buy
1,639
+18
+1% +$3.11K 0.23% 62
2022
Q3 		$265K Sell
1,621
-309
-16% -$52.3K 0.22% 62
2022
Q2 		$343K Sell
1,930
-390
-17% -$69.5K 0.16% 61
2022
Q1 		$411K Sell
2,320
-1,031
-31% -$175K 0.14% 63
2021
Q4 		$573K Sell
3,351
-1,622
-33% -$266K 0.17% 61
2021
Q3 		$804K Buy
4,973
+2,742
+123% +$468K 0.29% 56
2021
Q2 		$367K Sell
2,231
-150
-6% -$24.8K 0.14% 57
2021
Q1 		$391K Buy
2,381
+80
+3% +$12.9K 0.16% 59
2020
Q4 		$362K Sell
2,301
-256
-10% -$37.8K 0.15% 60
2020
Q3 		$381K Hold
2,557
– – 0.18% 61
2020
Q2 		$360K Sell
2,557
-1,447
-36% -$211K 0.18% 62
2020
Q1 		$525K Buy
4,004
+935
+30% +$133K 0.32% 57
2019
Q4 		$447K Sell
3,069
-5
-0.2% -$678 0.22% 58
2019
Q3 		$397K Sell
3,074
-401
-12% -$52.8K 0.21% 59
2019
Q2 		$484K Buy
3,475
+865
+33% +$120K 0.27% 60
2019
Q1 		$365K Sell
2,610
-5,418
-67% -$726K 0.24% 63
2018
Q4 		$1.04M Sell
8,028
-4,478
-36% -$625K 0.82% 47
2018
Q3 		$1.73M Sell
12,506
-2,346
-16% -$312K 1.18% 39
2018
Q2 		$1.8M Buy
14,852
+320
+2% +$39.9K 1.4% 37
2018
Q1 		$1.86M Sell
14,532
-310
-2% -$41.9K 1.67% 30
2017
Q4 		$2.07M Buy
14,842
+138
+0.9% +$19.2K 1.79% 30
2017
Q3 		$1.91M Sell
14,704
-910
-6% -$121K 1.74% 31
2017
Q2 		$2.07M Sell
15,614
-290
-2% -$37K 1.91% 25
2017
Q1 		$1.98M Sell
15,904
-481
-3% -$57.5K 1.86% 24
2016
Q4 		$1.89M Sell
16,385
-1,300
-7% -$150K 1.84% 25
2016
Q3 		$2.09M Buy
17,685
+300
+2% +$36.4K 2.05% 16
2016
Q2 		$2.11M Sell
17,385
-671
-4% -$76.2K 1.83% 16
2016
Q1 		$1.95M Sell
18,056
-230
-1% -$23.8K 1.74% 19
2015
Q4 		$1.88M Buy
+18,286
New +$1.84M 1.71% 20

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Nixon Peabody Trust's JNJ Position: Q2 2026 in Review

Nixon Peabody Trust increased its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, buying an estimated $120K and bringing the position to 22,335 shares worth $5.67M. The position accounts for 0.4% of the portfolio, ranked #58.

Nixon Peabody Trust first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. The position peaked at $17.7M in Q1 2024. 1,966 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nixon Peabody Trust held 22,335 shares of Johnson & Johnson worth $5.67M as of Q2 2026.
  • Nixon Peabody Trust bought 517 Johnson & Johnson shares in Q2 2026, an estimated $120K.
  • Johnson & Johnson made up 0.4% of Nixon Peabody Trust's portfolio in Q2 2026, its #58 holding.
  • Nixon Peabody Trust first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • Nixon Peabody Trust's Johnson & Johnson position peaked at $17.7M in Q1 2024.
  • 1,966 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.